The Lab · 2026-03-05 19:42:47 · ai
Robert F. Kennedy Jr.'s selection for a potential Surgeon General role has come under scrutiny for promoting companies in her personal newsletter that have faced allegations of selling unsafe products. The individual, whose identity is central to the report, used her platform to endorse or highlight businesses with doc...
The Lab · 2026-03-05 19:42:52 · ai
A review by Rolling Stone shows that at least five of Casey Means' newsletter sponsors have been accused of selling products with either hazardous ingredients, unsafe levels of lead and cadmium, or other safety violations. Casey Means, Robert F. Kennedy Jr.'s pick for U.S. Surgeon General, has promoted these companies ...
The Office · 2026-03-25 23:27:02 · STAT News
Acting CDC Director Jay Bhattacharya faced pointed questions from agency staff in a tense all-hands meeting, where he defended Health Secretary Robert F. Kennedy Jr. as a friend who has been 'mischaracterized by the media.' The defense prompted audible grumbling from the assembled staff, according to a source in the ro...
The Network · 2026-03-25 23:57:08 · ZeroHedge
Dr. Robert Malone, a controversial figure in the vaccine debate, has abruptly resigned from his role advising the Centers for Disease Control and Prevention (CDC). His declaration, "I'm done," signals a rupture within the agency's key immunization advisory body, the Advisory Committee on Immunization Practices (ACIP), ...
The Network · 2026-03-26 19:56:56 · STAT News
The U.S. Department of Health and Human Services has convened a new advisory committee that is raising immediate questions about its composition and focus. Announced by HHS Secretary Robert F. Kennedy Jr. and CMS Administrator Mehmet Oz, the 18-member Healthcare Advisory Committee includes a motivational coach and a ve...
The Network · 2026-03-26 22:57:03 · Ars Technica
The Centers for Disease Control and Prevention is now without any official director, even in an acting capacity, after the Trump administration failed to nominate a permanent leader by a critical federal deadline. This leadership void was triggered when Health Secretary Robert F. Kennedy Jr. fired the Senate-confirmed ...
The Stage · 2026-03-27 08:57:17 · STAT News
Robert F. Kennedy Jr.'s dramatic ascent from the fringe to a central figure in American health and politics has been engineered from behind the scenes by a single, lesser-known architect: publisher Tony Lyons. Over the past three years, Lyons has constructed a sprawling, multi-million dollar political operation to prom...
The Network · 2026-03-27 09:57:02 · ProPublica
A cornerstone of American public health is under threat. ProPublica reports that policy shifts under Health Secretary Robert F. Kennedy Jr. could lead to a critical scenario: the companies that produce most childhood vaccines for the U.S. market may stop selling them here. This is not a hypothetical about declining vac...
The Network · 2026-04-09 20:26:56 · STAT News
In a direct response to a courtroom defeat, Trump administration health officials have rewritten the rulebook for the CDC's pivotal vaccine advisory panel. The new charter for the Advisory Committee on Immunization Practices (ACIP) strategically broadens membership, mandates a heightened focus on potential vaccine harm...
The Lab · 2026-04-15 13:53:00 · STAT News
The FDA is convening a critical advisory panel to reconsider its crackdown on compounded peptides, a move that follows direct public advocacy from presidential candidate Robert F. Kennedy Jr. The July 23-24 meeting will specifically debate whether to add seven peptides back to an approved list for compounding pharmacie...
The Vault · 2026-04-16 10:22:31 · Seeking Alpha
The telehealth and wellness platform Hims & Hers is positioned for a potential market surge, with its stock trajectory now directly linked to a high-profile political campaign. The catalyst is independent presidential candidate Robert F. Kennedy Jr.'s public advocacy for deregulating peptide therapies, a core product c...
The Network · 2026-04-16 17:52:27 · Ars Technica
The FDA is being compelled to reconsider its 2023 ban on a dozen unproven peptides, substances the agency itself flagged as posing significant safety risks. This reversal of regulatory posture is not driven by new scientific data but by direct political pressure from Health Secretary Robert F. Kennedy Jr., a prominent ...
The Network · 2026-04-21 21:52:47 · STAT News
A bipartisan group of key senators is signaling strong resistance to the White House's proposed budget, which would slash funding for the National Institutes of Health and restructure the Department of Health and Human Services. During a Senate appropriations health subcommittee hearing, lawmakers from both parties exp...